Cantitate/Preț
Produs
Total produse
Vezi coșul
Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection de A. M. Gotto

Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection: Mathematics and Its Applications, cartea 8

Autor A. M. Gotto, Jr. Gotto, Antonio M., International Symposium on Multiple Risk
en Limba Engleză Hardback – 30 iun 1995
Patients with two or more risk factors have a very high risk of developing cardiovascular disease. It follows that the strategy for the intervention of multiple risk factors is in fact of paramount relevance in detecting patients at high risk of cardiovascular disease requiring therapeutic intervention. Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection also discusses risk factors from the point of view of biochemists and pharmacologists by addressing the mechanisms underlying the onset of hypertension, hyperlipoproteinaemia, hypercoagulability, and the possibility of therapeutic intervention. Audience: Biochemists, pharmacologists and clinical pharmacologists, specialists in the field of cardiovascular medicine seeking to keep abreast of current knowledge in the fast moving field of cardiovascular disease.
Citește tot Restrânge

Din seria Mathematics and Its Applications

  • Pairs of Compact Convex Sets: Fractional Arithmetic with Convex Sets
    Preț: 22874 lei
  • 18% Complementarity in Mathematics: A First Introduction to the Foundations of Mathematics and Its History
    Preț: 91848 lei
  • 15% Functional Integration and Semiclassical Expansions
    Preț: 62985 lei
  • 15% Bifurcation Theory, Mechanics and Physics: Mathematical Developments and Applications
    Preț: 63331 lei
  • 15% Properties and Chemistry of Biomolecular Systems
    Preț: 57468 lei
  • Functional Equations: History, Applications and Theory
    Preț: 38306 lei
  • 18% Fundamentals of General Topology: Problems and Exercises
    Preț: 92814 lei
  • 15% Quantum Groups and Related Topics
    Preț: 57005 lei
  • 5% Atrial Fibrillation, a Treatable Disease?
    Preț: 63642 lei
  • 15% Operator Commutation Relations: Commutation Relations for Operators, Semigroups, and Resolvents with Applications to Mathematical Physics and Representations of Lie Groups
    Preț: 63984 lei
  • 15% Partial Differential Equations: New Methods for Their Treatment and Solution
    Preț: 62999 lei
  • 15% Women in Ichthyology: An Anthology in Honour of Et, Ro and Genie
    Preț: 58753 lei
  • Multidimensional Systems Theory: Progress, Directions and Open Problems in Multidimensional Systems
    Preț: 38365 lei
  • 15% Wave Propagation: An Invariant Imbedding Approach
    Preț: 63317 lei
  • Special Functions: Group Theoretical Aspects and Applications
    Preț: 37475 lei
  • Stochastic Space—Time Models and Limit Theorems
    Preț: 38326 lei
  • 15% Magnetic Fields of Celestial Bodies
    Preț: 68607 lei
  • Combinatorial Complexes: A Mathematical Theory of Algorithms
    Preț: 37988 lei
  • The Assay of Spatially Random Material
    Preț: 37862 lei
  • 15% Information & On-Line Data in Astronomy
    Preț: 56830 lei
  • 15% Scattering by Obstacles
    Preț: 63525 lei
  • 15% Infrared Space Interferometry: Astrophysics & the Study of Earth-Like Planets
    Preț: 57022 lei
  • 20% Finite Element Methods and Navier-Stokes Equations
    Preț: 57741 lei
  • Mathematical Modelling in Biomedicine: Optimal Control of Biomedical Systems
    Preț: 38422 lei
  • 15% Mechanical Properties and Deformation Behavior of Materials Having Ultra-Fine Microstructures
    Preț: 58465 lei
  • 15% Stochastic Hydrology and Its Use in Water Resources Systems Simulation and Optimization
    Preț: 57751 lei
  • 15% Variational Principles of Continuum Mechanics with Engineering Applications: Volume 1: Critical Points Theory
    Preț: 63317 lei
  • 15% Elliptically Contoured Models in Statistics
    Preț: 63048 lei
  • Algebraic Structures and Operator Calculus: Volume I: Representations and Probability Theory
    Preț: 38105 lei
  • 15% Boolean Constructions in Universal Algebras
    Preț: 63048 lei
  • 15% Nonparametric Methods in Change Point Problems
    Preț: 62505 lei
  • Carleman’s Formulas in Complex Analysis: Theory and Applications
    Preț: 37841 lei

Preț: 64334 lei

Preț vechi: 67720 lei
-5% Nou

Puncte Express: 965
Preț estimativ în valută:
12311€ • 12911$ • 10266£

Carte tipărită la comandă

Livrare economică 07-21 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780792335030
ISBN-10: 0792335031
Pagini: 440
Dimensiuni: 160 x 240 mm
Greutate: 0.81 kg
Editura: Kluwer Academic Publishers
Seria Mathematics and Its Applications

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

Preface. I: Multiple Risk Factors in Population. 1. Lipid Risk Factors and the Regression of Atherosclerosis; A. M. Gotto Jr. 2. Multiple Risk Factors: What is Next? M. Higgins, C. Lenfant 3. Multiple Risk Factors in Northern Italy; G. A. Feruglio, D. Vanuzzo, G. Cesana, M. Ferrario on behalf of the MONICA- Friuli and MONICA-Brianza Study Groups. 4. Long-Term Associations between Hemostatic Variables and Ischemic Heart Disease; T. W. Meade. 5. Cardiovascular Gene Therapy: Possibilities and Realities; V. J. Dzau, R. Morishita, G. H. Gibbons. 6. Triglycerides and Coronary Heart Disease: An Update; M. H. Criqui. II: Lipids and Lipoproteins. 7. Factors Controlling Lipoprotein Metabolism; E. Sehayek, S. Eisenberg. 8. Apolipoproteins in the Treatment of Vascular and Nonvascular Disease; C. R. Sirtori. 9. Explorations of Postprandial Lipids in a Case of Homozygous APO B45.2; B. Jacotot, A. Piolot, M. Ayraut-Jarrier, N. Lemort, C. Martin, S. Braschi, F. Yen, B. Bihain. 10. Apolipoprotein E Binding and Hepatic Lipase-Mediated Catabolism Make Alternate Pathways in the Metabolism of Intermediate Lipoprotein Particles: Observation in Patients with Hepatic Lipase Deficiency; A. Yamamoto, Y. Ikeda, Z. Tsutsumi, A. Mori, A. Takagi, M. Tsushima. III: Critical Aspects of Vascular Protection of New Dihydropyridine Calcium Antagonists. 11. New Aspects of the Pharmacology of Dihydropyridine Calcium Antagonists; T. Godfraind, O. Feron, N. Morel, S. Salomone, M. Wibo. 12. Membrane Interaction of Lipophilic Dihydropyridines as New Mechanisms for Vascular Protection; G. Gaviraghi, D. Trist. 13. Mechanisms of Free Radical Oxidations and Vascular Damage: Protective Effect of Dihydropyridines; F. Ursini. 14. Lipophilic Dihydropyridines: New Opportunities for Prevention of Atherosclerosis; R. Paoletti. 15. Clinical Trial Design and Noninvasive Atherosclerosis Endpoints for Studying Lipophilic Dihydropyridines; M. G. Bond, M. Mercuri, R. Arens, F. Gianfrate for the ELSA Collaborative Research Group. IV: N-3 Fatty Acids and Cardiovascular Risk Factors. 16. The Biological Roles of n-e Fatty Acids: Metabolic and Nutritional Aspects; C. Galli. 17. Effect of Supplementation with Moderate Doses of n-3 Fatty Acid Ethyl Esters to Hypertriglyceridemic Patients on Lipid and Hemostatic Variables; E. Tremoli, S. Colli, P. Maderna, S. Eligini, E. Stragliotto, P. Risé, F. Pazzucconi, C. R. Sirtori, C. Galli. 18. Long-Lasting Inhibition of Platelet Aggregation Following a Relatively Short-Course Administration of n-3 Fatty Acid Ethyl Esters; A. M. Cerbone, T. Cusano, E. Tremoli, C. Galli, F. Cirillo, A. Coppola, E. Stragliotto, A. Amoriello, V. Marottoli, G. Vecchione, G. Di Minno. V: Diabetes. 19. Insulin Resistance and Cardiovascular Risk Factors in Noninsulin-Dependent Diabetes Mellitus; K. G. M. M. Alberti. 20. Glucose as a Risk Factor for Atherosclerosis; R. Bucala, A. Cerami. 21. Dyslipidemia in NIDDM: New Insights; M.-R. Taskinen, M. Syvänne, S. Lahdenperä. 22. Diabetes and Cardiovascular Risk: Epidemiological Aspects; S. M. Haffner. 23. Rational Treatment of the `Plurimetabolic Syndrome'; A. Tiengo, A. Avogaro, S. Del Prato. 24. Kidney Protection in Diabetes Mellitus; K. H. Rahn, M. Barenbrock, B. Suwelack, H. Hohage. 25. Association of Serum Uric Acid with Triglyceride Levels in Female Patients with NIDDM; W. Rathmann, H. Hauner, B. Haastert, K. Kirchner, F. A. Gries. 26. Cardiovascular Disease Prevention in the Elderly; G. Crepaldi, E. Manzato. VI: Diabetic Dyslipidemia and Atherosclerosis: Current Clinical Findings and Treatment Strategies. 27. Insulin Resistance and Coronary Heart Disease; G. M. Reaven. 28. Diabetic Dyslipidemia: The Asian Perspective; T.-Y. Tai, C.-J. Change, Y.-T. Lee. 29. Therapeutic Intervention in Diabetic Dyslipidemia; A. M. Gotto Jr. VII: Hypertension. 30. Red Blood Cell Cation Heteroexchange and Cardiovascular Risk; A. Semplicini, G. Ceolotto, M. Felice, A. Gebbin, A. Fontebasso, R. Valle, L. Serena, C. Dal Palù. 31. Hypertension in the Elderly with Special Focus on Side Effects; L. H. Lindholm. VIII: Therapeutic Interventions. 32. Drugs Directly Affecting the Arterial Wall; R. Paoletti, M. R. Soma. 33. The POSCH Trial: Importance of Cholesterol Lowering in Reducing Coronary Heart Disease Progression; C. T. Campos, H. Buchwald, the POSCH Group. 34. Three-Dimensional Reconstruction of Intracoronary Ultrasound Images: Technical Approaches, Clinical Applications, and Current Limitations in the Assessment of Vessel Dimensions; C. von Birgelen, C. Di Mario, W. Li, F. Prati, N. Bom, J. R. T. C. Roelandt, P. W. Serruys. IX: New Trends in the Use of Fibrates. 35. Metabolic Basis of the Atherogenic Lipoprotein Phenotype; C. J. Packard, J. Shepherd. 36. Fibrates: Modes of Action; A. L. Catapano. 37. Fenofibrate: A Safety Evaluation of a Large German Patient Population; K. U. Kirschgässler. X: New Insights on Cholesterol Controversy. 38. Plasma Cholesterol and Total Mortality; R. Paoletti, A. Poli. 39. Cholesterol-Lowering Coronary Angiography Trials: An Overview; L. J. Hirsch. 40. Treatment of Hyperlipidemia in Specific Types of Patients: The Elderly, Women, and Patients with Coronary Heart Disease; D. R. Illingworth. 41. An Italian Multicenter Study on the Efficacy and Tolerability of Simvastatin in Male Patients with Essential Hypertension and Primary Hypercholesterolemia; A. Salvetti, G. Argenio, G. Bernini. 42. Effects of Simvastatin Treatment on Thromboxane (TX) Biosynthesis and Platelet Function in Type II Hypercholesterolemia (HC); A. Notarbartolo. XI: Risk Factors. 43. Risk Factor Interactions Involving Pressor Agents; G. V. R. Born, L. E. Cardona-Sanclemente. 44. Hemodynamic and Adrenergic Effects of Cigarette Smoking; G. Grassi, A. Lanfranchi, S. Vailati, G. Seravalle, B. M. Cattaneo, G. Mancia. 45. Serum Uric Acid and 18-Year Cardiovascular Mortality in the Chicago Heart Association Detection Project in Industry; A. R. Dyer, R. Stamler, J. Stamler, D. Garside. 46. The Impact of High-Density Lipoprotein Cholesterol on Cardiovascular Risk: The Bezafibrate Infarction Prevention (BIP) Study; U. Goldbourt for the BIP Study Research Group. 47. Triglycerides and the Fibrinolytic System; E. Tremoli, L. Sironi, M. Camera, L. Mannucci, L. Prati, C. Banfi, D. Baldassare, L. Mussoni. 48. Apolipoprotein E and Alzheimer's Disease; G. Franceschini, L. Calabresi, C. R. Sirtori, G. B. Frisoni, C. Geroldi, A. Bianchetti, M. Trabucchi, S. Govoni. 49. Apolipoprotein A1: A Natural Kidney-Protective Agent? J. R. Paterniti, Jr., B. F. Burkey, D. France, H. Wong, X. Ma, B. Brand, C. Abuhani, M. R. Diffenderfer, J. B. Marsh, E. A. Fisher. XII: Vascular Reactivity and Remodeling. 50. Noninvasive Evaluation of Arterial Reactivity in Patients with Premature Onset Coronary Disease; P. Rubba, C. Sapio, P. Pauciullo, A. Iannuzzi, G. Iannuzzo, D. Iorio, N. Spampinato, M. Mancini. 51. Long-Chain Acylcarnitine as Membrane Stabilizer; W. C. Hülsmann, A. Peschechera. XIII: Protective Effects of Moderate Consumption of Alcohol on the Incidence of Coronary Heart Disease. 52. Protective Effects of Moderate Consumption of Alcohol on the Incidence of Coronary Heart Disease; M. H. Criqui. 53. Alcohol Consumption: Weighing the Cardiovascular Benefit with the Overall Health Risk; E. B. Rimm. 54. Alcohol and Atherosclerosis; A. Catapano. Index.